Editor's Picks
Editor's Picks
Teladoc Health (NYSE:TDOC) Faces Challenges Amidst Insider Sale and Revenue Guidance Cut
September 3, 2026
Editor's Picks
Top Stock Losers: Ultragenyx, Polestar, Inverse ETFs Plunge
September 3, 2026Top Stock Market Losers: Ultragenyx Trial Failure, Polestar Outlook Cut, and Inverse ETFs Lead Declines Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) plunged after its experimental Angelman syndrome treatment failed a Phase...
Editor's Picks
Top Stock Gainers: ChargePoint (CHPT) Leads Market Surge
September 3, 2026
Ciena (CIEN) Stock Falls Despite Strong Q3 Results & AI Demand
September 3, 2026
We will not share your information & you can unsubscribe at any time. You agree to our terms of service & privacy policy. You agree to receive emails & correspondence from Nextmemealert.